Nadim, B. 2020
|
2011.08-2018.09
|
P1
|
hCG ratio (48/0h) 0.8-0.99, and D7 hCG rises;
hCG ratio (48/0h) >1 EP
|
|
|
M4 |
≥5% |
Bobdiwala, S. 2020 |
2015.01-2017.01 |
M6 |
Step 1 progesterone>2nmol/L
and Step 2 M6 model≥5% |
Van Calster, B. 2016 |
2003.07-2013.12 |
M6 |
Step 1
progesterone>2nmol/L and Step 2 M6 model≥5% |
|
|
M4 |
≥5% EP |
|
|
Progesterone cut-offs(10nmol/L) |
>10nmol/L high
risk |
Fistouris, J. 2016 |
2011.01.01-2013.12.31 |
M4 |
≥5% EP high
risk |
|
|
hCG ratio |
hCG ratio (48/0h) changes between
0.87-1.66 |
Bobdiwala, S. 2016 |
2012.08-2013.12 |
M4 |
≥5% EP high
risk |
Van Calster, B. 2013 |
2003.07-2011 |
M4 |
≥5% EP high
risk |
Barnhart, K. T. 2010
|
2003.02.01-2007.09.30(US)
2003.07.18-2004.10.09(UK)
|
M4
|
≥5% EP high risk
|
Condous, G. 2007b |
2002.03.04-2003.07.17 |
M4 |
≥5% EP high
risk |
|
|
M5 |
combined clinical symptoms as predictive factors with
M4 |
Bignardi, T. 2008 |
2001.06.25-2004.10.09 |
hCG ratio (hCG 48/0 h) |
hCG
ratio (48/0h) changes between 0.87-1.66 |
Kirk, E. 2007 |
2005.02.21-2006.02.20 |
M4 |
≥5% EP high
risk |
Kirk, E. 2006 |
2003.08.07-2004.12.18 |
M1 |
>0.21 |
Condous, G. 2005b |
2001.6.25-2003.4.14 |
hCG cut-offs(1000) |
>1000 IU/L |
|
|
hCGcut-offs(1500) |
>1500 IU/L |
|
|
hCGcut-offs(2000) |
>2000 IU/L |
Condous, G. 2005a |
2001.6.25-2003.4.14 |
Progesterone&hCG cut-offs |
Progesterone 10-50nmol/l and hCG>25u/l |
Condous, G. 2004 |
2001.06-2002.12 |
M1 |
>0.21 |
Guha, S. 2014 |
2005.02-2012.08 |
M4 |
≥5% |
|
|
Progesterone cut-offs(10nmol/l) |
>10nmol/L |
|
|
hCG ratio(0.87-1.66) |
0.87-1.66 |
Kaplan, B. C. 1996 |
1991.08-1992.09 |
hCG cut-offs(1000mIU/mL) |
≤1000mIU/mL |
Dart, R. G. 1999b |
1991.08-1998.08 |
hCG ratio+Ultrasonography |
hCG
ratio 0.5-1.66 and an empty uterus at ultrasound |
Dart, R. G. 2002
|
1995.01-2000.08
|
Ultrasonography
|
Empty endometrial cavity with or without a thickened
endometrium.
|
Dart, R. G. 1998 |
1991.08-1994.12 |
hCG cut-offs(1000mIU/mL) |
≤1000mIU/mL |
Day, A. 2009 |
2004.01-2006.12 |
Progesterone cut-offs |
>10nmol/L |
Mol, B. W. 1998 |
1993.09-1996.04 |
hCG cut-offs |
>1000IU/L |
|
|
hCG cut-offs |
>1500IU/L |
|
|
hCG cut-offs |
>2000IU/L |
Dart, R. G. 1999a |
1991.08-1997.08 |
hCG cut-offs |
≤1000mIU/mL |
Condous, G. 2007a |
2002.03-2003.07 |
M1 |
>0.21 |
Dart, R. G. 1996 |
1991.08-1994.12 |
hCG cut-off |
>3000 |
El Bishry, G. 2008
|
-
|
hCG+progesterone cut-offs
|
16≤P<80 and hCG>25
P>80 and hCG >1000
|
Nowacek GE. 1999 |
- |
FFN |
FFN>50ng/mL |
Morse, C. B. 2012 |
2007.10-2009.06 |
hCG ratio |
0.53~0.64-1.35 |
Florio P. 2007 |
2004.11-2005.09 |
Progesterone cut-offs |
5.01
ng/ml |
|
|
hCG cut-offs |
658IU/L |
|
|
Activin A |
0.37ng/ml |
Zee, J. 2014 |
2007-2009 |
hCG ratio |
<1.66 |